The International Digestive Disease Forum (IDDF) 2020 - Institute of Digestive Disease, CUHK

Connect with us:

#IDDF2020

22 Nov

23 Nov

Speaker

Rupa BANERJEE

Asian Institute of Gastroenterology, Hyderabad, India

Senior Consultant Gastroenterologist, Department of Gastroenterology
Director, Inflammatory Bowel Diseases (IBD) Center

Asian Healthcare Foundation, Hyderabad, India

Director of IBD research

Dr. Rupa Banerjee is a senior consultant gastroenterologist in the department of Gastroenterology and the Director of the Inflammatory Bowel Diseases (IBD) center at the Asian Institute of Gastroenterology, Hyderabad, India. She is also the director of IBD research with the Asian Healthcare Foundation, Hyderabad.

Dr. Rupa established the first dedicated IBD center of excellence in India in 2004. She has designed and maintains a 6000-patient database and biorepository for the center detailing the demographics, type and course of disease and response to treatment in the Indian subpopulation. Her primary focus has been optimal & affordable multidisciplinary care of IBD.

Dr Rupa is actively involved in research on inflammatory bowel disease in the Asian region focusing on the epidemiology, microbiota, & genetic profile of this population for optimizing and individualizing the management of IBD and the development of low-cost treatment options. She has been the principal investigator for numerous clinical trials in ulcerative colitis and Crohn's disease.

Dr. Rupa has initiated the IBD-ENC (IBD –Emerging Nations Consortium) with over 20 countries South Asia, Middle East and Africa to promote collaborative work on IBD in this part of the world. She has been the key person to design the interactive web platform for the IBD-ENC(www.ibdenc.org) for IBD news, latest publications, discussing challenging cases and having the unique provision of development of personal IBD registry for members.

She organizes the AIG IBD Summit, an exclusive IBD meeting every alternate year with over 1500 delegates from India and neighbouring countries.

Dr. Rupa is the author of numerous papers and articles in peer-reviewed journals, has contributed to book chapters and lectured widely at both national and international level. She has published a book on advanced gastrointestinal imaging and 2 books on IBD management in clinical practice.

Francis CHAN

The Chinese University of Hong Kong

Dean, Faculty of Medicine
Choh-Ming Li Professor of Medicine and Therapeutics
Director, Centre for Gut Microbiota Research

Professor Chan Ka Leung, Francis JP is the Dean of Faculty of Medicine, the Choh-Ming Li Professor of Medicine and Therapeutics of The Chinese University of Hong Kong (CUHK). He graduated with honours in CUHK in 1988. After completion of his postgraduate training as a Croucher Foundation research fellow in Canada, he joined his alma mater in 1997. Since then he has risen through the ranks to become Professor of Medicine and Therapeutics in 2005. He had contributed to academic management services in the Faculty of Medicine in various capacities – previously as Director of Institute of Digestive Disease, Assistant Dean (General Affairs), and Associate Dean (Clinical). He is an internationally renowned clinician-scientist in gastrointestinal complications of NSAIDs and aspirin and has published over 400 full scientific articles in high impact international journals such as The New England Journal of Medicine and The Lancet. His h-index is 78. In recognition of his scholarly achievements, he was conferred Doctor of Science by CUHK in December 2011.

Henry CHAN

The Chinese University of Hong Kong

Honorary Clinical Professor, Faculty of Medicine

Union Hospital, Hong Kong

Deputy Chief Hospital Manager

Professor Henry Lik Yuen Chan is a Deputy Chief Hospital Manager of Union Hospital and an Honorary Clinical Professor of Faculty of Medicine, The Chinese University of Hong Kong. Professor Chan is a global lead investigator in publications on peginterferon, telbivudine, and tenofovir for the treatment of viral hepatitis B, and has advised 13 pharmaceutical and biotechnology companies for hepatitis B cure. He is the chairman of the Strategic Technical Advisory Committee on Viral Hepatitis for the Western Pacific Regional Office of WHO since 2015. He is currently a Global Council Member in IASL. He has received numerous research awards including Okuda Lectureship in Asia Pacific Digestive Week in 2018. He has published over 450 papers and is awarded Highly Cited Researcher (Cross Field) by Clarivate Analytics in 2018 and 2019 for producing multiple top 1% cited papers under Web of Science.

Stephen CHAN

The Chinese University of Hong Kong

Associate (Clinical) Professor, Department of Clinical Oncology

Dr Stephen L. Chan is the Associate (Clinical) Professor at the Department of Clinical Oncology of the Chinese University of Hong Kong. His main interest in research is clinical and translational studies on hepatobiliary-pancreatic and neuroendocrine cancers. Internationally, he is serving as the Associate Editor for the Journal of Hepatology and editorial board members of Liver International. Dr Chan is also an international member of the NCI Hepatobiliary Task Force of the Gastrointestinal Steering Committee in the United States. Dr Chan has published over 130 peer-reviewed papers, with awards of young investigator award and gold medal dissertation by the Hong Kong College of Physician. Locally, Dr Chan has established a charity Hand-in-hand cancer foundation to provide education and assistance to cancer patients.

Wah-kheong CHAN

University of Malaya, Malaysia

Professor

University of Malaya Medical Centre, Malaysia

Senior Consultant, Gastroenterologist and Hepatologist

University of Malaya Specialist Centre, Malaysia

Senior Consultant, Gastroenterologist and Hepatologist

Dr Chan is Professor at the University of Malaya and Senior Consultant Gastroenterologist and Hepatologist at the University of Malaya Medical Centre and the University of Malaya Specialist Centre. He is a Member of the Academy of Medicine of Malaysia and a Committee Member for the Malaysian Society of Gastroenterology and Hepatology. He is the Scientific Co-Chair for Hepatology for the Asia Pacific Digestive Week 2020. He is a member of the Asia-Pacific Working Party on Non-Alcoholic Fatty Liver Disease, the Gut and Obesity in Asia (GO ASIA) Workgroup, and the Global NASH Council. He is Associate Editor for the Journal of Gastroenterology and Hepatology and is a reviewer for several international journals. He has published over 60 full papers in peer-reviewed journals and presented in both local and international conferences. His main area of research interest is non-alcoholic fatty liver disease.

Philip CHIU

The Chinese University of Hong Kong

Professor, Institute of Digestive Disease
Professor, Division of Upper GI and Metabolic Surgery, Department of Surgery
Director, CUHK Jockey Club Minimal Invasive Surgical Skills Centre
Director, Shaw Endoscopy Centre Prince of Wales Hospital
Co-Director, Chow Yuk Ho Technology Centre for Innovative Medicine
Assistant Dean (External Affair), Faculty of Medicine

Philip Chiu is currently Professor of Division of Upper GI and Metabolic Surgery, Department of Surgery, Institute of Digestive Disease; Director of CUHK Jockey Club Minimal Invasive Surgical Skills Centre; Director of CUHK Chow Yuk Ho Technology Centre for Innovative Medicine and Assistant Dean (External Affairs), Faculty of Medicine, Chinese University of Hong Kong. Professor Chiu graduated from the Faculty of Medicine, the Chinese University of Hong Kong in 1994 with two scholarships. He became a fellow of the Royal College of Surgeons of Edinburgh, Hong Kong Academy of Medicine in 2001 and received his Doctor of Medicine at CUHK in 2009. Prof. Chiu was the first to perform endoscopic submucosal dissection (ESD) for treatment of early GI cancers in Hong Kong. In 2010, he performed the first Per-oral Endoscopic Myotomy (P.O.E.M.) in Hong Kong. His research interests include upper gastrointestinal bleeding, esophageal cancer and minimally invasive and robotic esophagectomy, novel endoscopic technologies for the diagnosis of early GI cancers, ESD and novel endoscopic procedures as well as Natural Orifices Transluminal Endoscopic Surgery (NOTES). Currently, he is honorary treasurer of the College of Surgeons of Hong Kong. He has published more than 170 peer reviewed manuscripts and 4 book chapters. He received numerous prestigious awards including State Scientific Technology and Progress Award from People’s Republic of China in 2007, 2nd class award in Technological Advancement, Ministry of Education of the People’s Republic of China in 2011. He served as Yeoh Ghim Seng Visiting Professor at Department of Surgery, National University of Singapore from 2014-2017. His research on POEM was awarded best of DDW 2011 and the first prize of ASGE world cup of endoscopy 2012. He was selected as Asia Pacific Digestive Week JGHF Emerging Leader Lectureship in 2016 and Global Outstanding Chinese Youth 2016. He is currently co-editor of Endoscopy and subject editor for Surgical Endoscopy.

Vinay DHIR

SL Raheja Hospital, Mumbai, India

Chairman, Institute of Digestive and Liver Care

Dr Vinay Dhir MD,DNB,FASGE(USA),FSGEI, is currently the Chairman of the Institute of Digestive and Liver Care (IDL Care), SL Raheja Hospital, Mumbai. He is the founder of the School of EUS, which is awarded the Centre of Excellence status by the Asian EUS Group. He is also the Chairman of the India EUS Club, and president-elect of the Gastrointestinal Endoscopy Society of India. Dr Dhir has more than 120 publications and book chapters to his credit. He has devised an all in one training model for interventional EUS, and the popular railroad technique for linear pancreatico-biliary EUS. Dr Dhir has trained more than 150 students worldwide in EUS techniques over the past 20 years. His active research interests are pancreatico-biliary disorders and interventional EUS.

Geert D’HAENS

University of Amsterdam, The Netherlands

Full Professor of Gastroenterology

Amsterdam University Medical Centers

Director of IBD Clinical Research and Clinical Trials

Edward GANE

University of Auckland, New Zealand

Professor of Medicine

Auckland City Hospital, New Zealand

Deputy Director, New Zealand Liver Unit

Edward Gane is a Professor of Medicine at the University of Auckland, New Zealand and Deputy Director of the New Zealand Liver Unit at Auckland City Hospital. He is an investigator for many international clinical trials of new therapies for chronic viral hepatitis and has published about 300 articles. Ed chairs the Ministry of Health HCV implementation committee and in 2017 was awarded the New Zealand Innovator of the Year for his work towards HCV elimination in NZ.

Subrata GHOSH

University of Birmingham, United Kingdom

Director, Institute of Translational Medicine
Professor of Translational Medicine

Subrata Ghosh is the Director of the Institute of Translational Medicine and Professor of Translational Medicine, University of Birmingham. He took up this position on the 1st of June 2016. He moved from Canada where he was the Professor of Medicine at the University of Calgary. He was cross-appointed as Professor of Immunology and microbiology and was an adjunct professor in the department of veterinary medicine. He was the Head of the Department of Medicine at Cumming School of Medicine, the University of Calgary and the Zone Clinical Department Head, Calgary Zone, Alberta Health Services. Previously, he was the Chair of Gastroenterology and Professor of Gastroenterology at the Imperial College London, Hammersmith Hospital and associate professor of gastroenterology at the University of Edinburgh. Professor Ghosh is a Fellow of the Canadian Academy of Health Sciences and a member of the International Organization for the Study of IBD. He is a past editor in chief of the Canadian Journal of Gastroenterology and Hepatology, editor in chief of World Journal of Gastroenterology and associate editor of Gut, and sits on the editorial boards of several journals. He served on the Scientific Advisory Committee of the Crohn’s and Colitis Canada and Chaired its of Advocacy Committee and he was the chairman of the medical advisors of the Crohn’s and Colitis UK. Prof Ghosh has published over 470 manuscripts (h index 87). He has delivered over 600 international lectures. His research interests are focused on translational immunology of inflammatory bowel disease and novel therapeutic approaches.

Juanda Leo HARTONO

National University Hospital, Singapore

Consultant, Division of Gastroenterology & Hepatology

National University of Singapore

Assistant Professor, Yong Loo Lin School of Medicine

Juanda-leo Hartono Following the completion of basic medical degree and Master of Internal Medicine, Dr. Juanda completed his gastroenterology specialist training in National University Hospital, Singapore. He is currently the Clinical Director of Gastroenterology & Hepatology Division and the Director of Inflammatory Bowel Service in National University Hospital of Singapore. Besides research, he is actively involved in teaching and is a Core Faculty for Post-Graduate Gastroenterology Training Programme.

Wei JIA

Hong Kong Baptist University

Cheung On Tak Endowed Professor in Chinese Medicine and Systems Biology
Director, Hong Kong Phenome Research Centre

Shanghai Jiao Tong University affiliated 6th People’s Hospital

Adjunct Professor
Director, Center for Translational Medicine

Prof. JIA Wei is Cheung On Tak Endowed Professor in Chinese Medicine and Systems Biology, and Director of the Hong Kong Phenome Research Centre, Hong Kong Baptist University. He is also the Adjunct Professor and Director of the Center for Translational Medicine, Shanghai Jiao Tong University affiliated 6th People’s Hospital.

Dr Jia’s M.S. and Ph.D. were completed at the University of Missouri-Columbia in radiopharmaceutical sciences. He is the author of over 300 scientific papers and 6 books and serves on the editorial boards for 9 scientific journals in the fields of metabolomic and translational research. His current research interest focuses on the molecular mechanisms that link metabolic disruptions in gut microbial-host co-metabolism to metabolic disorders and gastrointestinal cancer. Dr Jia directs a well-recognized metabolomics laboratory, focusing on the quantitative analysis of endogenous small-molecule metabolites from biological specimens including blood, urine, saliva, and tissues of experimental animals and human subjects.

Ray Kim

The Stanford University Medical Center

Professor of Medicine (Gastroenterology and Hepatology)

W. Ray Kim, MD, is Professor and Chief in the Division of Gastroenterology and Hepatology at Stanford University School of Medicine. Prior to assuming this post in November 2013, Dr Kim was Professor of Medicine at Mayo Clinic College of Medicine. Dr Kim earned his medical diploma at Seoul National University in Korea. He underwent training in gastroenterology and hepatology at Mayo Clinic in Rochester, MN. He also holds a Master in Science Degree in patient oriented research from Seoul National University and a Master in Business Administration from the University of Pennsylvania. He has served on the Governing Board of the American Association for the Study of Liver Disease (AASLD), where he currently chairs the Global Outreach and Engagement Committee.

Dr Kim’s research interest has been in epidemiology and outcomes studies in chronic liver disease and liver cancer. His contribution to science to date includes the following: (1) Measures for risk stratification in patients with cirrhosis, including the Model for End Stage Liver Disease (MELD) and MELD-Na scores; (2) Population-based epidemiology of liver disease in Olmsted County, MN; (3) Liver transplant allocation and distribution policy analyses; and (4) health economic analyses and technology assessment. Dr Kim is recognized as a content expert on the topic of long term effects of antiviral therapy for patients with chronic viral hepatitis.

Ernst KUIPERS

Erasmus MC University Medical Center Rotterdam, The Netherlands

Professor of Medicine and CEO

Louis LAU

Prince of Wales Hospital

Resident Specialist, Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics

Dr Lau graduated from the Faculty of Medicine, The Chinese University of Hong Kong in 2012, receiving numerous prizes including the Dean’s List, College Head’s List, Philips Health Care Prize along with six other scholarships. He joined the Department of Medicine and Therapeutics, Prince of Wales Hospital after graduation. He completed his training in Gastroenterology and Hepatology under the mentorship of Professor Justin Wu and Professor Grace Wong. He is currently serving as a Resident Specialist in the Prince of Wales Hospital.

Dr Lau is also enthusiastic in medical education and received the Exemplary Teachers’ Award from the Faculty of Medicine in 2016-2017. He has special research interests in the early diagnosis and treatment of gastrointestinal cancers, endoscopic submucosal dissection and fecal microbiota transplantation. He has published peer-reviewed articles including papers in The New England Journal of Medicine, Gastroenterology and Gut. He was awarded the Poster of Distinction and the Certificate of Recognition for Early Career Investigators from the American Gastroenterological Association in Digestive Disease Week 2018 and 2019 respectively. He also attended local and overseas conferences on advanced endoscopy including the Asian Novel Bio-Imaging and Intervention Group Osaka Train-the-Trainer Course 2019. He was the recipient of the Gold Medal, Best Thesis Award in 2019 and the Young Investigator Research Grant in 2020 from the Hong Kong College of Physicians.

Jyhming LIOU

National Taiwan University Cancer Center

Director, Department of Medicine

National Taiwan University

Clinical Professor, Department of Internal Medicine, College of Medicine

Jyhming Liou is currently the Director of Department of Medicine, National Taiwan University Cancer Center and Clinical Professor of Internal Medicine at College of Medicine, National Taiwan University. He received his medical degree from National Yang-Ming University in 1998 and his Ph.D. from Graduate Institute of Epidemiology and Preventive Medicine of National Taiwan University in 2013. He has focused his researches in the molecular epidemiology of GI tract cancers, treatment of refractory H. pylori infection, and changes of antibiotic resistance and gut microbiota after H. pylori eradication. He has published several trials regarding the treatment of H. pylori infection in top journals, including Lancet, Gastroenterology, and GUT.
He has received several awards, including Young Investigator Award of National Taiwan University Hospital, (2012), Ching-Shing Medical Award (2013), Ta-You Wu Memorial Award (2013), Outstanding Research Award of National Taiwan University Hospital (2018), Outstanding Research Award of Ministry of Science and Technology, Taiwan (2018), and Emerging Leader Award of APDW 2019.

Rashid LUI

Prince of Wales Hospital

Associate Consultant, Department of Medicine and Therapeutics

Dr. Rashid Lui graduated from the Faculty of Medicine, CUHK in 2010 with Distinctions in Paediatrics, Obstetrics & Gynaecology and Microbiology, Subject Prize in Clinical Oncology, Dean's List of the Faculty of Medicine (2007, 2008, 2009), Head's List of Chung Chi College (2007), 12 other scholarships, and was selected as a Member of the Dr. and Mrs. Tzu Leung Ho Honour Society. He completed his specialist training in Gastroenterology and Hepatology in 2016, and is currently pursuing further specialist training in Medical Oncology under the mentorship of Professor Brigette Ma.

Dr. Lui has received various accolades including the Certificate of Recognition for Young Investigators at Digestive Disease Week 2018, the Young Investigator’s Award (2nd Prize) at Asian Pacific Digestive Week 2018, the Award for Obtaining the Highest Score in Advanced Internal Medicine Exit Assessment and the Young Investigator Research Grant from the Hong Kong College of Physicians in 2018, the Best Oral Presentation Award at the Hospital Authority Convention 2018, and the Exemplary Teachers' Award 2017-2018 from the Faculty of Medicine. In 2019, he was conferred as the inaugural Stanley Ho Scholar at St Anne’s College in partnership with the Wellcome Centre for Human Genetics, University of Oxford where he pursued training in personalised medicine. In addition, he was nominated as a Distinguished Young Fellow of the Hong Kong Academy of Medicine and received the Best Original Paper Award from the Hong Kong Medical Journal in the same year.

Dr Lui’s research interests are focused on gastrointestinal oncology particularly in young onset colorectal cancer, pre-malignant lesions of the gastrointestinal tract, advanced endoscopy and gut microbiota modulation. He has published in peer-reviewed journals including the New England Journal of Medicine, Gut, Gastroenterology and Nature Communications. He currently serves as the Honorary Treasurer of the Hong Kong Association for the Study of Liver Diseases, the Social Media Editor for the Journal of Gastroenterology and Hepatology, an Editor and Member of the Expert Advisory Panel on Social Media of the Hong Kong Medical Journal, and an Editorial Board Member of the World Journal of Gastrointestinal Endoscopy.

Brigette MA

The Chinese University of Hong Kong

Professor, Department of Clinical Oncology
Honorary Consultant, Department of Clinical Oncology

Dr Brigette Ma is currently Professor (CA2) and Honorary Consultant at the Department of Clinical Oncology, Chinese University of Hong Kong (CUHK), Medical Director of the Phase I Clinical Trial Centre (Oncology), Co-Director of the Cancer Drug Testing Unit and Chair, NTEC-CUHK ethics committee. She received her undergraduate degree with Honours at Monash University, Australia, and was awarded Fellow of the Royal Australasian College of Physicians (2001), Fellow of Hong Kong College of Physicians (2004), and Doctor of Medicine in 2014 (CUHK). She underwent training in Medical Oncology at the Peter MacCallum Cancer Institute, Melbourne, and was Research Fellow at the Princess Margaret Hospital, Toronto, Canada. She has published over 150 peer- reviewed papers. Notably, she is a Faculty member of the European Society of Medical Oncology (ESMO) in Gastrointestinal Cancer, and was a member of the Consensus Working Group for the management of metastatic colorectal cancer; executive member of the National Cancer Institute (Bethesda, USA) Head and Neck Cancer Steering Committee - Clinical Trials Planning Group on Nasopharyngeal Cancer, Co-chair of Widely Metastatic Group (since 2017); and mentor and committee member of the Women in Cancer Research of the American Association of Cancer Research (since 2016). Her other current roles include: member of the Joint Scientific Committee for Phase 1 Clinical Trials, Centre of Health Protection, Hong Kong Hospital Authority; Chair/ member of the Scientific Committee at the 2016 American Association of Cancer Research, ESMO (GI cancer) meeting in Barcelona, (since 2017) and ESMO (Asia) conference in Singapore.

Siew NG

The Chinese University of Hong Kong

Professor, Institute of Digestive Disease
Professor, Department of Medicine and Therapeutics
Professor, State Key Laboratory of Digestive Disease (CUHK)
Associate Director, Centre for Gut Microbiota Research
Assistant Dean (Development), Faculty of Medicine
Director, Microbiota Innovation Center (M@gIC), Health@InnoHK

Siew Ng is Professor at the Department of Medicine and Therapeutics, The Chinese University of Hong Kong and Honorary Senior Lecturer at the University of Melbourne. She graduated from St Bartholomew’s and the Royal London School of Medicine and Dentistry and was awarded a PhD in immunology and intestinal inflammation by Imperial College London in 2009. Her research interests include the epidemiology, genetics and microbiota of inflammatory bowel disease and colorectal cancer biomarker and screening. She has published over 120 peer-reviewed articles including publications in Nature Genetics, Gut and Gastroenterology. She leads the first large scale Asia-Pacific epidemiologic IBD study and the Asian Microbiota consortium. She is a peer reviewer of 14 journals and editorial board members for 5 biomedical journals. She is President of the Hong Kong IBD Society, Management Committee of the International IBD Genetics Consortium, and Deputy Secretary of the International Organization of Inflammatory Bowel Disease. In 2014, she received the Distinguished Research Paper Award for Young Investigators and the JGHF Emerging Leader Lectureship Award.

Eddy OOI

Duke-NUS Medical School, Singapore

Adjunct Associate Professor

Gleneagles Medical Centre, Singapore

Consultant Gastroenterologist

Farrer Park Medical Centre, Singapore

Consultant Gastroenterologist

Singapore General Hospital, Singapore

Visiting Consultant, Inflammatory Bowel Disease Centre

Dr Eddy Choon Jin Ooi obtained his MBBS from National University of Singapore and attained his higher degree from the Royal College of Physicians, United Kingdom. He is a fellow of the Royal College of Physicians, Edinburgh and the Academy of Medicine Singapore. From 1998 to 2000, he trained at the Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital and Harvard Medical School.

He is an Adjunct Associate Professor at the Duke-NUS Medical School. He is a Consultant Gastroenterologist at Gleneagles and Farrer Park Medical Centre and a Visiting Consultant to the Inflammatory Bowel Disease Centre at Singapore General Hospital.

He previously served as Chairman of the Chapter of Gastroenterologists, Academy of Medicine Singapore and President of the Gastroenterological Society of Singapore. He is the Vice President of the Asian Pacific Association of Gastroenterology (APAGE) and the lead for APAGE Working Group on IBD. The IBD group has been pivotal in producing many IBD consensus to help guide clinicians in the diagnosis and management of IBD in Asia.

Kewin SIAH

National University Hospital, Singapore

Gastroenterology Consultant

Dr Kewin Siah completed his undergraduate studies at Royal Free and University College Medical School (University College London). He had undergone advanced colonoscopy training in Japan (Kyoto Prefectural University of Medicine) as part of the JSGE research fellowship award and received NMRC award to perform Irritable Bowel Syndrome research in world-renowned Oppenheimer Neurobiology of Stress Centre in UCLA (University of California, Los Angeles) where he concentrated on brain-gut-microbiota research. He is currently a gastroenterology consultant at the National University Hospital where he runs the Gastro-Motility Lab and Functional Gastrointestinal Disorders Clinic. He is the President of Singapore’s IBS Support Group and an Executive Committee of National Foundation Digestive Disease. He is also a Council Member of Asian Neurogastroenterology & Motility Association.

Jun SUN

University of Illinois at Chicago (UIC), USA

Professor of Medicine

Dr Jun Sun is a tenured Professor of Medicine at the University of Illinois at Chicago (UIC), U.S.A. She is an elected Fellow of American Gastroenterological Associate (AGA) and Fellow of American Physiological Society. She is the Chair for the AGA Microbiome and Microbial Therapy Section. Her research interests are host-microbiome interactions in inflammation and cancer. Dr Sun has published over 180 scientific articles in peer-reviewed journals. She is the leading editor of three books, including a recent Nature/Spring book entitled “Mechanisms underlying host-microbiome interactions in pathophysiology of human diseases.” She serves the editorial board of more than 10 peer-reviewed international scientific journals. She services study sections for the NIH, American Cancer Society, and other national and international research foundations. She is actively involved in advocating microbiome research at the international, national and institutional levels. Her research is supported by the NIH, DOD, VA, and other research awards.

Joseph SUNG

The Chinese University of Hong Kong

Director, Institute of Digestive Disease
Mok Hing Yiu Professor of Medicine, Department of Medicine and Therapeutics
Director, State Key Laboratory of Digestive Disease (CUHK)
Co-Director, S.H. Ho Centre for Digestive Health
Co-Director, Stanley Ho Big Data Decision Analytics Research Centre
Director, CUHK Jockey Club Multi-Cancer Prevention Programme
Founding Director & Advisor, Stanley Ho Centre for Emerging Infectious Diseases, JC School of Public Health and Primary Care